Skip to main content

Want a detailed portfolio tracker?

Legend Biotech (LEGN) P/E (2020 - 2026)

Legend Biotech (LEGN) P/E from Jun 5, 2020 to Jul 21, 2026. The TTM Legend Biotech (LEGN) P/E is -17.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Legend Biotech (LEGN)

YearP/EChange
2026-17.35+28.65%
2025-13.49-59.78%
2024-33.54+67.83%
2023-19.98+6.38%
2022-18.78+10.28%
2021-17.03+53.27%
2020-11.11N/A

Comparison Legend Biotech (LEGN) P/E with competitors

Legend Biotech (LEGN) P/E is -17.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.43%
FGENFibroGen Inc0.24-101.38%
CHRSCoherus Biosciences Inc0.85-104.89%
FBIOFortress Biotech Inc0.95-105.47%
ORMPOramed Pharmaceuticals Inc1.50-108.66%
AGENAgenus Inc3.01-117.34%
INVAInnoviva Inc3.15-118.18%
VXRTVaxart Inc3.55-120.46%
CRMDCorMedix Inc3.63-120.91%
CVACCureVac N.V.4.45-125.62%
GLPGGalapagos NV4.86-128.00%
SRPTSarepta Therapeutics Inc4.88-128.13%
ABEOAbeona Therapeutics Inc5.39-131.05%
ABUSArbutus Biopharma Corp5.60-132.25%
ZVRAZevra Therapeutics Inc5.89-133.93%
SPROSpero Therapeutics Inc6.23-135.89%
CGENCompugen Ltd6.31-136.39%
RIGLRigel Pharmaceuticals6.87-139.60%
SLXNSilexion Therapeutics Corp7.30-142.05%
OMEROmeros Corporation9.26-153.36%
AUPHAurinia Pharmaceuticals Inc9.58-155.24%
PLXProtalix BioTherapeutics Inc10.89-162.76%
ACADAcadia Pharmaceuticals Inc11.73-167.59%
TBPHTheravance Biopharma Inc12.26-170.66%
ADMAAdma Biologics Inc12.42-171.56%
HRMYHarmony Biosciences Holdings Inc13.82-179.64%
SABSSAB Biotherapeutics Inc14.14-181.46%
NAGENiagen Bioscience Inc14.82-185.39%
INCYIncyte Corp15.82-191.18%
REGNRegeneron Pharmaceuticals Inc15.86-191.38%
PBYIPuma Biotechnology Inc17.32-199.79%
CPRXCatalyst Pharmaceuticals Inc17.44-200.50%
EXELExelixis Inc17.54-201.07%
TGTXTG Therapeutics Inc18.97-209.30%
MDXGMimedx Group Inc20.55-218.44%
XOMAXOMA Royalty Corp22.87-231.82%
ARGXArgen X SE24.30-240.03%
CTMXCytomX Therapeutics Inc24.82-243.04%
XOMAOXOMA Royalty Corp25.34-246.06%
HALOHalozyme Therapeutics Inc25.62-247.67%
XOMAPXOMA Royalty Corp25.67-247.93%
VRTXVertex Pharmaceuticals Inc27.99-261.33%
RPRXRoyalty Pharma plc - Class A28.69-265.32%
SLNOSoleno Therapeutics Inc29.02-267.21%
ASNDAscendis Pharma A/S30.09-273.38%
LGNDLigand Pharmaceuticals Inc - Class B37.91-318.48%
APLSApellis Pharmaceuticals Inc39.02-324.87%
BMRNBiomarin Pharmaceutical Inc42.21-343.26%
KRYSKrystal Biotech Inc45.34-361.31%
ONCBeiGene Ltd69.54-500.75%
PHARPharming Group N.V.75.03-532.36%
TECHBio-Techne Corp101.96-687.57%
VCELVericel Corp109.92-733.46%
ALNYAlnylam Pharmaceuticals Inc117.96-779.82%
GMABGenmab140.29-908.48%
TLXTelix Pharmaceuticals Ltd162.15-1034.47%
CORTCorcept Therapeutics Inc212.86-1326.67%